MX2011008400A - Lactobacillus rhamnosus cncm i-4096 y el control del peso. - Google Patents
Lactobacillus rhamnosus cncm i-4096 y el control del peso.Info
- Publication number
- MX2011008400A MX2011008400A MX2011008400A MX2011008400A MX2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A
- Authority
- MX
- Mexico
- Prior art keywords
- lactobacillus rhamnosus
- weight control
- rhamnosus cncm
- present
- obesity
- Prior art date
Links
- 241000218588 Lactobacillus rhamnosus Species 0.000 title abstract 2
- 238000004260 weight control Methods 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 3
- 235000020824 obesity Nutrition 0.000 abstract 3
- 230000037221 weight management Effects 0.000 abstract 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En general, la presente invención se refiere al campo de la obesidad. En particular, la presente invención se refiere al uso de probióticos para apoyar el manejo del peso y para tratar o prevenir la obesidad. Una modalidad de la presente invención se refiere al uso del Lactobacillus rhamnosus CNCM I-4096 para la preparación de una composición para apoyar el manejo del peso, promover la pérdida de peso y/o para tratar la obesidad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09152435A EP2216035A1 (en) | 2009-02-10 | 2009-02-10 | Lactobacillus rhamnosus CNCM I-4096 and weight control |
PCT/EP2010/051364 WO2010091993A1 (en) | 2009-02-10 | 2010-02-04 | Lactobacillus rhamnosus cncm i-4096 and weight control |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011008400A true MX2011008400A (es) | 2011-09-01 |
Family
ID=40762310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011008400A MX2011008400A (es) | 2009-02-10 | 2010-02-04 | Lactobacillus rhamnosus cncm i-4096 y el control del peso. |
Country Status (8)
Country | Link |
---|---|
US (1) | US8318150B2 (es) |
EP (2) | EP2216035A1 (es) |
CN (1) | CN102316881B (es) |
AU (1) | AU2010213010B2 (es) |
BR (1) | BRPI1008327A2 (es) |
CL (1) | CL2011001937A1 (es) |
MX (1) | MX2011008400A (es) |
WO (1) | WO2010091993A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2691111B1 (en) * | 2011-03-31 | 2017-09-20 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications |
WO2014071633A1 (en) * | 2012-11-12 | 2014-05-15 | Companie Gervais Danone | Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance |
WO2014072771A1 (en) * | 2012-11-12 | 2014-05-15 | Compagnie Gervais Danone | Lactobacillus rhamnosus strain for reducing body fat accumulation |
CA2907526A1 (en) * | 2013-03-28 | 2014-10-02 | Nestec S.A. | Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention |
FR3004621B1 (fr) * | 2013-04-19 | 2015-05-15 | Gervais Danone Sa | Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique |
WO2015159125A1 (en) * | 2014-04-15 | 2015-10-22 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis |
CN103947962B (zh) * | 2014-05-09 | 2015-10-28 | 上海盛世中侬农业科技发展有限公司 | 一种减肥食品 |
KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
WO2017026635A1 (ko) * | 2015-08-12 | 2017-02-16 | 씨제이제일제당(주) | 신규한 락토바실러스 속 미생물 및 이를 포함하는 동물 사료용 조성물 |
CN109757730B (zh) * | 2019-01-31 | 2021-06-04 | 山东环亿生物科技有限公司 | 一种具有降血脂、血压以及血糖的组合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
BR0207948A (pt) * | 2001-03-09 | 2004-07-27 | Produits Nestel S A Soc D | Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade |
US20040001898A1 (en) * | 2002-06-26 | 2004-01-01 | Armand Malnoe | Compositions and methods for detoxification and cancer prevention |
US7001756B1 (en) | 2004-02-19 | 2006-02-21 | Genmont Biotech Inc. | Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
CN100396770C (zh) | 2004-03-19 | 2008-06-25 | 景岳生物科技股份有限公司 | 新的微生物鼠李糖乳杆菌gm-020及其治疗肥胖的用途 |
KR100686557B1 (ko) | 2004-08-16 | 2007-02-23 | 씨제이 주식회사 | 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품 |
EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
-
2009
- 2009-02-10 EP EP09152435A patent/EP2216035A1/en not_active Withdrawn
-
2010
- 2010-02-04 CN CN2010800073021A patent/CN102316881B/zh not_active Expired - Fee Related
- 2010-02-04 MX MX2011008400A patent/MX2011008400A/es active IP Right Grant
- 2010-02-04 EP EP10702152A patent/EP2396012A1/en not_active Withdrawn
- 2010-02-04 WO PCT/EP2010/051364 patent/WO2010091993A1/en active Application Filing
- 2010-02-04 US US13/147,985 patent/US8318150B2/en not_active Expired - Fee Related
- 2010-02-04 BR BRPI1008327A patent/BRPI1008327A2/pt not_active IP Right Cessation
- 2010-02-04 AU AU2010213010A patent/AU2010213010B2/en not_active Ceased
-
2011
- 2011-08-10 CL CL2011001937A patent/CL2011001937A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010213010B2 (en) | 2014-10-30 |
EP2216035A1 (en) | 2010-08-11 |
CN102316881B (zh) | 2013-08-07 |
EP2396012A1 (en) | 2011-12-21 |
WO2010091993A1 (en) | 2010-08-19 |
AU2010213010A1 (en) | 2011-08-25 |
US20110293569A1 (en) | 2011-12-01 |
BRPI1008327A2 (pt) | 2016-02-23 |
US8318150B2 (en) | 2012-11-27 |
CN102316881A (zh) | 2012-01-11 |
CL2011001937A1 (es) | 2012-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011008398A (es) | Lactobacillus helveticus cncm i-4095 y el control del peso. | |
MX2011008400A (es) | Lactobacillus rhamnosus cncm i-4096 y el control del peso. | |
MX2011008399A (es) | Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso. | |
MY155516A (en) | Lactobacillus rhamnosus and weight control | |
MX2012003612A (es) | Bifidobacterium longum atcc baa-99 (bl999) y control de peso. | |
ATE537707T1 (de) | Lactobacillus paracasei und gewichtskontrolle | |
GB2465051B (en) | Probiotic bifidobacterium strains | |
PT2626076T (pt) | Utilizações terapêuticas de lactobacillus salivarus ls01 22775 | |
PL2498789T3 (pl) | Probiotyczny szczep bifidobacterium | |
HK1141554A1 (en) | Probiotic bifidobacterium strains | |
HK1173468A1 (en) | Novel lactobacillus plantarum and composition comprising the same | |
PL2485743T3 (pl) | Szczepy Lactobacillus plantarum jako czynniki hipocholesterolemiczne | |
PT2332520T (pt) | Lactobacillus paracasei para tratar os pontos de senescência e/ou melasma | |
PL2475764T3 (pl) | Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii | |
PL2268792T3 (pl) | Szczep lactobacillus rhamnosus | |
MX2011005527A (es) | Uso de la bacteria de acido lactico para tratar o prevenir el eczema. | |
PL2568815T3 (pl) | Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei | |
PL2276498T3 (pl) | Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii | |
MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
MX2015005898A (es) | Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo. | |
AP2012006139A0 (en) | Composition comprising strains of lactobacillus fermentum. | |
MX2015005897A (es) | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal. | |
MX346332B (es) | Cepas probioticas para aumentar la resistencia transepitelial. | |
PL2593539T3 (pl) | Zastosowanie manganu do wzmacniania wzrostu bakterii L.Casei w mieszanych kulturach | |
MX350212B (es) | Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |